{"sourcedb":"DevicePMAs@therightstef","sourceid":"P970020_S035","text":"Approval for the addition of an indication to use the 4.5 mm and 5.0 mm ultra otw and rx for the treatment of saphenous vein graft (svg) lesions.  The multi-link rx ultra and multi-link otw ultra coronary stent system will include the following indication:  1) patients with symptomatic ischemic heart disease due to discrete de novo or restenotic native coronary artery lesions (length \u003C=25 mm) with reference vessel eiameters ranging from 3.5 mm to 5.0 mm;  2) patients with symptomatic ischemic heart disease due to lesions in saphenous vein bypass grafts (length \u003C=35) with reference vessel diameters ranging from 3.5 mm to 5.0 mm; and  3) treatment of abrupt or threatened abrupt closure in patients with failed interventional therapy in lesions (\u003C=35 mm in length with reference diameters in the range of 3.5 mm to 5.0 mm.  Long term outcome for this permanent implant is unknown at present.  Note: the 38 mm lentgh stents are solely indicated for use in patients with abrupt or threatened abrupt closure and patients with lesions in saphenous vein bypass grafts.","project":"consensus_PMA_Age_Indications"}